Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,143 | 880 | 1,588 | 2,463 | 3,151 |
| Receivables | 82 | 135 | 259 | 52 | 197 |
| Other current assets | 54 | 54 | 54 | 54 | 54 |
| TOTAL | $1,279 | $1,069 | $1,901 | $2,692 | $3,402 |
| Non-Current Assets | |||||
| PPE Net | 132 | 142 | 143 | 102 | 114 |
| TOTAL | $132 | $142 | $143 | $102 | $114 |
| Total Assets | $1,411 | $1,211 | $2,044 | $2,794 | $3,516 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 306 | N/A | N/A | N/A | N/A |
| Accrued Expenses | 269 | 284 | 301 | 456 | 142 |
| TOTAL | $623 | $437 | $569 | $583 | $699 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 64 | 75 | 68 | 95 | 85 |
| TOTAL | $67 | $84 | $81 | $115 | $110 |
| Total Liabilities | $690 | $521 | $650 | $698 | $809 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 0 | 75 |
| Retained earnings | -13,320 | -12,163 | -11,123 | -10,418 | -9,404 |
| Other shareholders' equity | 1,885 | 1,575 | 1,247 | 1,264 | 1,210 |
| TOTAL | $721 | $690 | $1,394 | $2,096 | $2,707 |
| Total Liabilities And Equity | $1,411 | $1,211 | $2,044 | $2,794 | $3,516 |